Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors
dc.contributor.author
dc.date.accessioned
2024-01-09T15:43:20Z
dc.date.available
2024-01-09T15:43:20Z
dc.date.issued
2023-08-23
dc.identifier.uri
dc.description.abstract
Background: Cognitive impairment is present in 40–65% of patients with multiple sclerosis (pwMS). Objectively measured cognitive performance often does not match patients' subjective perception of their own performance.
Objective: We aimed to compare cognitive performance and subjective perception of cognitive deficits between pwMS and healthy controls (HCs), as well as the accuracy of subjective perception.
Methods: In total, 54 HC and 112 pwMS (relapsing–remitting, RRMS, and progressive PMS) underwent neuropsychological evaluation and completed perceived deficit, fatigue, and anxiety–depression scales. Participants were classified according to their consistency between subjective self-evaluation of cognitive abilities and objective cognitive performance to assess accuracy. Regression models were used to compare cognitive performance between groups and explore factors explaining inaccuracy in the estimation of cognitive performance.
Results: PMS showed greater and more widespread cognitive differences with HC than RRMS. No differences were found between pwMS and HC in the perception of deficit. PMS had higher ratios of overestimators. In explaining inaccuracy, fatigue and cognitive preservation were found to be risk factors for underestimation, whereas physical disability and cognitive impairment were risk factors for overestimation.
Conclusion: PwMS have metacognitive knowledge impairments. This study provides new information about metacognition, data on the prevalence of impairments over a relatively large sample of PwMS, and new insights into factors explaining it. Anosognosia, related to cognitive impairment, may be present in pwMS. Fatigue is a key factor in underestimating cognition
dc.description.sponsorship
This work was supported by the Departament de Salut of the Generalitat de Catalunya [SLT017/20/000115, 2021]; Instituto de Salud Carlos III, RICORS -Red de Enfermedades Inflamatorias [RD21/0002/0063, 2021]; and Norvartis, who partially funded the ConnectiMS project
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Frontiers Media
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.3389/fpsyg.2023.1163112
dc.relation.ispartof
Frontiers in Psychology, 2023, vol. 14, p. 1163112
dc.relation.ispartofseries
Articles publicats (D-CM)
dc.rights
Attribution 4.0 International
dc.rights.uri
dc.subject
dc.title
Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
038162
dc.type.peerreviewed
peer-reviewed
dc.identifier.eissn
1664-1078